Departments

About the department

Department name (English): Regional Reference Centre for inherited Bleeding Disorders

Department name (original): SSD Centro Hub Emofilia e MEC

Subnetworks of expertise:

• Bleeding - Coagulation disorders

Healthcare provider: Azienda Ospedaliero-Universitaria di Parma

Diseases covered by the department:

• Rare coagulation disorder
• Rare hemorrhagic disorder
• Rare hemorrhagic disorder due to a coagulation factors defect
• Rare hemorrhagic disorder due to a constitutional coagulation factors defect
• Hemophilia
• Hemophilia A
• Severe hemophilia A
• Moderately severe hemophilia A
• Mild hemophilia A
• Symptomatic form of hemophilia A in female carriers
• Hemophilia B
• Severe hemophilia B
• Moderately severe hemophilia B
• Mild hemophilia B
• Symptomatic form of hemophilia B in female carriers
• Congenital factor V deficiency
• Congenital fibrinogen deficiency
• Familial afibrinogenemia
• Familial dysfibrinogenemia
• Familial hypofibrinogenemia
• Familial hypodysfibrinogenemia
• Congenital factor XIII deficiency
• Von Willebrand disease
• Von Willebrand disease type 1
• Von Willebrand disease type 2
• Von Willebrand disease type 2A
• Von Willebrand disease type 2B
• Von Willebrand disease type 2M
• Von Willebrand disease type 2N
• Von Willebrand disease type 3
• Congenital factor XI deficiency
• Congenital high-molecular-weight kininogen deficiency
• Congenital prekallikrein deficiency
• Combined deficiency of factor V and factor VIII
• Congenital vitamin K-dependent coagulation factors deficiency
• Congenital factor VII deficiency
• Congenital factor II deficiency
• Congenital factor X deficiency
• Hereditary combined deficiency of vitamin K-dependent clotting factors
• Thrombomodulin-related bleeding disorder
• Rare hemorrhagic disorder due to an acquired coagulation factor defect
• Acquired prothrombin deficiency
• Acquired hemophilia
• Acquired von Willebrand syndrome
• Rare hemorrhagic disorder due to a platelet anomaly
• Rare hemorrhagic disorder due to a constitutional platelet anomaly
• Rare hemorrhagic disorder due to a constitutional thrombocytopenia
• Rare hemorrhagic disorder due to a qualitative platelet defect
• Glanzmann thrombasthenia
• Pseudo-von Willebrand disease
• Bleeding diathesis due to a collagen receptor defect
• Rare hemorrhagic disorder due to an acquired platelet anomaly

Service offered

• Prevention and genetic counseling
• Diagnostics
• Treatment and care

Patients covered

• Pediatrics
• Adults
• Ageing

Department e-mail: centroemofilia(ELIMINAR)@ao.pr.it

Department phone number: +39 0521 703971

Description:
The Hub Centre for Hemophilia and inherited bleeding disorders takes care of congenital and acquired hemorrhagic diseases. More than 700 patients, adults and children coming also from other regions, are followed for diagnostic and therapeutic health services. The centre offers, from the suspicion until diagnosis and therapy of bleeding diseases, a global care thanks to a multidisciplinary team: hematologist, orthopedic, pediatrician, physiatrist and genetic counselling and diagnostics through a collaboration with other Departments of the Hospital (the molecular screening of Haemophilia A and B patients, genetic tests on suspected carriers and prenatal diagnosis, genetic analysis in patients with Factor VII and Factor XI congenital deficiency, von Willebrand disease are performed). Psychological support, when needed, is offered thanks to the Patient’s Association (AVES Onlus). The Centre has been identified as Regional Reference Centre of the “Hub & Spoke” Network of Inherited Bleeding Disorders of Emilia Romagna Region in 2002, with coordination and management role. The HC staff is composed by 4 haemotologists, 1 nurse , 1 molecular biologist and a study coordinator. The HC doctors are available on call 24/24h. The HC offers availability of hospitalization in specialistic departments in case of emergency and/or invasive and surgical procedures (pediatric, internal medicine, orthopedic, surgery, dentist surgery etc). The Parma HC coordinates national and international studies on IBD and participates at international network of the European Haemophilia Safety Surveillance (EUHASS project) since 2008. On February 2014 we obtained the Haemophilia Comprehensive Care Centre Certification by EUropean HAemophlia NETwork (EUHANET).